Our results suggest RACK1 as a downstream target gene of TGF-β1 involved in the modulation of liver fibrogenesis, and propose a strategy to target RACK1 for liver fibrosis treatment. This evidence concerns the gene TGFB1 and Hepatic fibrosis.